Data obtained by univariate survival analysis
. | No. . | Deaths caused by ALCL . | Percentage of patients alive after 5 years* . | P† . |
---|---|---|---|---|
Active caspase 3-positive cells | ||||
5% or less | 39 | 17 | 50 | .007 |
More than 5% | 13 | 0 | 100 | |
Percentage Bcl-2–positive cells | ||||
Less than 50% | 47 | 11 | 75 | .0004 |
50% or more | 17 | 11 | 30 | |
Pl9 expression | ||||
Negative | 39 | 11 | 70 | < .0001 |
Positive | 6 | 6 | 0 | |
ALK status | ||||
Positive | 25 | 1 | 95 | .0001 |
Negative | 39 | 21 | 45 |
. | No. . | Deaths caused by ALCL . | Percentage of patients alive after 5 years* . | P† . |
---|---|---|---|---|
Active caspase 3-positive cells | ||||
5% or less | 39 | 17 | 50 | .007 |
More than 5% | 13 | 0 | 100 | |
Percentage Bcl-2–positive cells | ||||
Less than 50% | 47 | 11 | 75 | .0004 |
50% or more | 17 | 11 | 30 | |
Pl9 expression | ||||
Negative | 39 | 11 | 70 | < .0001 |
Positive | 6 | 6 | 0 | |
ALK status | ||||
Positive | 25 | 1 | 95 | .0001 |
Negative | 39 | 21 | 45 |